Maxim Mokin1, Elad I Levy2, Adnan H Siddiqui2, Mayank Goyal3, Raul G Nogueira4, Dileep R Yavagal5, Vitor M Pereira6, Jeffrey L Saver7. 1. Department of Neurosurgery, University of South Florida, Tampa, Florida, USA. 2. Department of Neurosurgery, State University of New York at Buffalo, Buffalo, New York, USA. 3. Departments of Radiology and Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 4. Department of Neurology, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia, USA. 5. Department of Neurology and Neurosurgery, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, Florida, USA. 6. Division of Neuroradiology and Division of Neurosurgery, Department of Medical Imaging and Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada. 7. Department of Neurology, Comprehensive Stroke Center, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.
Abstract
BACKGROUND: The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. OBJECTIVE: To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. METHODS:CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). RESULTS:The mean age of the 69 patients who formed the study cohort was 63.2±13.1 years, mean National Institutes of HealthStroke Scale score was 16.8±4.5, and 55% of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups (p<0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). CONCLUSIONS: The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
RCT Entities:
BACKGROUND: The clot burden score (CBS) was developed as a tool to evaluate the extent of intracranial thrombus burden in patients with anterior circulation acute ischemic stroke. CBS is based on the presence or absence of contrast opacification on CT angiography (CTA). Its value in predicting radiographic and clinical outcomes in patients given endovascular stroke therapy remains unknown. OBJECTIVE: To evaluate the relationship between CBS and outcomes after stent retriever thrombectomy in the interventional arm of the SWIFT PRIME trial. METHODS: CBS was calculated for the endovascular arm (IV tissue plasminogen activator plus Solitaire stent retriever) of SWIFT PRIME using baseline CTA. The cohort of 69 patients was divided into three groups according to their CBS values: CBS 0-5 (n=14), CBS 6-7 (n=23), and CBS 8-9 (n=32). RESULTS: The mean age of the 69 patients who formed the study cohort was 63.2±13.1 years, mean National Institutes of Health Stroke Scale score was 16.8±4.5, and 55% of the patients were male. There was no difference in clinical characteristics among the three groups, except for the baseline Alberta Stroke Program Early CT Score (p=0.049). The site of proximal occlusion varied significantly among the three groups (p<0.001). Rates of successful recanalization (TICI 2b/3), complete recanalization (TICI 3 only) and of good clinical outcome at 3 months were similar among the three groups (p=0.24, p=0.35, and p=0.52, respectively). CONCLUSIONS: The combination of IV thrombolysis and stent retriever thrombectomy with the Solitaire device is highly effective in achieving successful recanalization and a good clinical outcome throughout the entire range of CBS values. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Jun-Soo Byun; Patrick Nicholson; Christopher A Hilditch; Anderson Chun On Tsang; Vitor Mendes Pereira; Timo Krings; Yibin Fang; Waleed Brinjikji Journal: Interv Neuroradiol Date: 2019-02-04 Impact factor: 1.610
Authors: Rosanna Rossi; Seán Fitzgerald; Sara M Gil; Oana M Mereuta; Andrew Douglas; Abhay Pandit; Paul Brennan; Sarah Power; Jack Alderson; Alan O'Hare; Michael Gilvarry; Ray McCarthy; Klearchos Psychogios; Georgios Magoufis; Georgios Tsivgoulis; István Szikora; Katarina Jood; Petra Redfors; Annika Nordanstig; Erik Ceder; Turgut Tatlisumak; Alexandros Rentzos; John Thornton; Karen M Doyle Journal: Eur Stroke J Date: 2021-07-07